Catalyst Pharmaceuticals, Inc.

The current price of CPRX is 15.35 USD — it has increased by 0.07% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Catalyst Pharmaceuticals, Inc. stocks are traded under the ticker CPRX.

Catalyst Pharmaceuticals, Inc. is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.

CPRX stock is 4.36% volatile and has beta coefficient of 1.33. Check out the list of the most volatile stocks — is Catalyst Pharmaceuticals, Inc. there?

One year price forecast for Catalyst Pharmaceuticals, Inc. has a max estimate of 34.00 USD and a min estimate of 22.00 USD.

CPRX earnings for the last quarter are −0.29 USD per share, whereas the estimation was −0.30 USD resulting in a 3.33% surprise. The estimated earnings for the next quarter are 0.27 USD per share. See more details about Catalyst Pharmaceuticals, Inc. earnings.

Catalyst Pharmaceuticals, Inc. revenue for the last quarter amounts to ‪102.62 M‬ USD despite the estimated figure of ‪100.37 M‬ USD. In the next quarter revenue is expected to reach ‪105.93 M‬ USD.

Yes, you can track Catalyst Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.

CPRX net income for the last quarter is ‪34.84 M‬ USD, while the quarter before that showed ‪−30.76 M‬ USD of net income which accounts for 213.26% change. Track more Catalyst Pharmaceuticals, Inc. financial stats to get the full picture.

Today Catalyst Pharmaceuticals, Inc. has the market capitalization of ‪1.81 B‬, it has increased by 1.64% over the last week.

No, CPRX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, CPRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Catalyst Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.

CPRX reached its all-time high on Jan 13, 2023 with the price of 22.11 USD, and its all-time low was 0.37 USD and was reached on Nov 13, 2012.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has 167.00 employees. See our rating of the largest employees — is Catalyst Pharmaceuticals, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Catalyst Pharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Catalyst Pharmaceuticals, Inc. stock shows the buy signal. See more of Catalyst Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on Catalyst Pharmaceuticals, Inc. future price: according to them, CPRX price has a max estimate of 34.00 USD and a min estimate of 22.00 USD. Read a more detailed Catalyst Pharmaceuticals, Inc. forecast: see what analysts think of Catalyst Pharmaceuticals, Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Catalyst Pharmaceuticals, Inc. EBITDA is ‪119.89 M‬ USD, and current EBITDA margin is 30.12%. See more stats in Catalyst Pharmaceuticals, Inc. financial statements.